The question
Do cancers mainly escape immunity by permanently exhausting immune cells?
This is the specific idea being tested.
The Hypothesis Critic · A guide for everyone
Immune Checkpoint Exhaustion
Do cancers mainly escape immunity by permanently exhausting immune cells?
What you need to knowImmune exhaustion matters, but it is not established as the one main route by which solid tumours escape.Relative explanatory fit: Alternative ranked ahead
Why the alternative fits better: Responsive immune-cell precursors and their surroundings help sustain tumour control. Other barriers also affect treatment response.
Review summary
Claim assessed: Checkpoint-driven, epigenetically fixed CD8+ T-cell exhaustion is the dominant mechanism by which human solid tumours evade immune control.
Finding: The preregistered scope-matched gate SC5 yields Γ. Defined experimental lineage and tumour-control sensitivities reach Ζ; clinical checkpoint efficacy alone can reach Η in selected indications, but neither establishes terminal-state mediation or cross-solid-tumour dominance. The weakest-link bundle would be Β because of the observational existence subclaim; it is not the registered gate.
Key points
- SC1: Tumour-infiltrating T cells enter a reproducible dysfunctional state with inhibitory receptors and lost polyfunctionality. — HSEF Β, Moderate confidence.
- SC2: Exhaustion is a distinct TOX-associated lineage maintained by defined epigenetic programmes. — HSEF Ζ, Moderate confidence.
- SC3: The exhaustion programme causally constrains tumour control. — HSEF Ζ, Moderate confidence.
- SC4: PD-1 blockade restores tumour control by reversing terminally exhausted T-cell states. — HSEF Γ, Moderate confidence.
- SC5: Exhaustion is the dominant evasion mechanism across human solid tumours. — HSEF Γ, Moderate confidence.
Verdict and review details
- Evidence grade
- HSEF Γ — Mechanistically plausible, partial system support
- Confidence
- Moderate
- Framework
- HSEF v5.3
- Review date
- Published
- Review attribution (recorded)
- Codex
Evidence scope: 69 primary reports; cutoff 2026-10-05; bounded critical review, not exhaustive systematic review.
The grade applies to the stated claim. Model rankings and individual subclaim grades remain separate from the overall causal-evidence grade.
Full scientific assessment and references · Scorecard (JSON) · Review source (Markdown)
The result at a glance
Immune exhaustion matters, but it is not established as the one main route by which solid tumours escape.
Read the labels in this illustration
THE MAIN FINDING Immune exhaustion matters, but it is not established as the one main route by which solid tumours escape. The idea Do cancers mainly escape immunity by permanently exhausting immune cells? Tumour persists Immune cells exhausted Escape via exhaustion Proposed chain — plausible, not established What fits better Best fit in this review Immune-cell renewal and surroundings Renewing precursors arrive Cancer cells Active immune cells Exhausted cells Renewing precursors What remains uncertain Which barrier matters most in a given tumour How precursor renewal is sustained or lost How exhaustion and other barriers interact Evidence comes from cells, animals, and people — each setting carries different weight. Responsive immune-cell precursors and their surroundings help sustain tumour control. Other barriers also affect treatment response. Conceptual illustration
Best fit in this review
Immune-cell renewal and surroundings
Responsive immune-cell precursors and their surroundings help sustain tumour control. Other barriers also affect treatment response.
Evidence for the stated claim
Plausible, not established
A higher rank means a better fit to the evidence in this comparison. It does not prove every part of the leading explanation.
Which explanation fits?
Another explanation fits better.
A separate question from the causal evidence grade
How does this explanation compare with alternatives?
Alternative ranked aheadThe reviewed hypothesis ranks 5 among 5 models compared; 1 alternative model(s) hold first rank for this stated claim.
Claim under review: rank 5 among 5 compared models.
Leading explanation: Progenitor-supported contextual immune control.
Position in this comparison: Last recorded rank.
The causal grade asks how well the stated causal claim is established. This comparison asks which of the assessed explanations fits the reviewed findings better. A leading explanation can remain unproven. Models can overlap or include the tested mechanism; an alternative ahead does not make that mechanism irrelevant. These ordinal ranks apply within this review; they do not measure the size of a difference or rank scientific strength across topics.
Read the labels in this illustration
TWO EXPLANATIONS, COMPARED A · The idea under review Do cancers mainly escape immunity by permanently exhausting immune cells? Proposed chain Tumour persists Cells exhausted Escape Each arrow is a proposal, not a proven step. Responsive immune-cell precursors and their surroundings help sustain tumour control. Other barriers also affect treatment response. B · Leading explanation Immune-cell renewal and surroundings Another explanation fits better Renewal plus surroundings (proposed links are dashed) A better fit is not proof of every part of the explanation. These explanations can overlap. Conceptual illustration
Idea being tested · rank 5
Do cancers mainly escape immunity by permanently exhausting immune cells?
Plausible, not established for the stated claim.
Best fit in this review · rank 1
Immune-cell renewal and surroundings
Responsive immune-cell precursors and their surroundings help sustain tumour control. Other barriers also affect treatment response.
These explanations can overlap. Ranking their fit to the evidence is separate from deciding how firmly a cause has been established.
See all the explanations compared
Rank 1: Progenitor-supported contextual immune control — Responsive precursors, niches and ongoing differentiation sustain antitumour immunity.
Rank 2: Antigen-presentation loss and immunoediting — Tumour recognition fails through HLA, B2M or IFNgamma pathway defects.
Rank 3: Stromal exclusion and niche failure — Fibroblast programs and absent APC niches limit access or support.
Rank 4: Myeloid and regulatory-cell suppression — TAM, Treg and glucocorticoid circuits restrain effector immunity and priming.
Rank 5: Dominant fixed checkpoint exhaustion — A checkpoint-induced irreversible CD8 program is the central escape mechanism across human solid tumours.
What this means
?
Plausible, not established
Immune exhaustion matters, but it is not established as the one main route by which solid tumours escape.
Evidence rating: Γ · Moderate confidence. How the evidence was assessed.
The important distinction
Responsive immune-cell precursors and their surroundings help sustain tumour control. Other barriers also affect treatment response.
Health and treatment
This is an assessment of a causal explanation, not proof that a particular supplement, diet, test, or treatment improves health. A treatment claim needs studies that test the intervention in people and measure meaningful benefits and harms. These findings can help frame research and informed clinical questions, but they do not identify what is right for one person.
From an idea to an explanation
Seeing two things together does not prove one causes the other.
What is observed?
Look for the proposed factor and the outcome, in the people or systems covered by the claim.
What else explains it?
Immune-cell renewal and surroundings. Responsive immune-cell precursors and their surroundings help sustain tumour control. Other barriers also affect treatment response.
What test tells them apart?
Track immune-cell families and test separate barriers to tumour control in the same setting.
Key questions
The key parts of the idea
These illustrations show the key questions tested in the review. They are conceptual drawings, not microscope images or experimental results.
What to test next
What evidence would make the answer clearer?
Read the labels in this illustration
WHAT WOULD MAKE THE ANSWER CLEARER A research question Track immune-cell families and test separate barriers to tumour control in the same setting. then then Change the proposed cause Proposed test Block one barrier at a time No change — control group Both groups are followed over time. Measure the relevant outcome Immune-cell families Tumour control Barrier effects Cell states over time Measured in both groups. Check the result independently First team measures Second team repeats An independent check of the result. Same measures, fresh eyes — no shared data until the end. Setting: cells, animals and people This storyboard shows the logic of a test. It does not show a result. The question is which barriers actually limit tumour control — and in which setting. Conceptual illustration
A useful next question
Track immune-cell families and test separate barriers to tumour control in the same setting.
Change the proposed cause
Check that the intended change really happened.
Measure the relevant outcome
Allow for other factors and compare with suitable controls.
Check whether it holds up
Look for independent confirmation and the limits of the effect.
These are questions for research, not a claim that the proposed studies have already succeeded.
Read the scientific study designs
Proposed tests: 1 test design(s) are registered in the scorecard.
In plain terms, researchers would change the proposed cause, check that it changed as intended, then measure a meaningful outcome while controlling plausible alternatives. The result should be able to support or count against the claim—not only show that a pathway exists.
Experiment 1: Registered boundary experiment
Study design: A prospective multicancer study enrolls prespecified inflamed antigen-presenting, excluded and presentation-defective strata; randomizes matched checkpoint, lineage-reprogramming and alternative-barrier interventions; tracks pretreatment terminal and progenitor tumour-reactive clones separately with state, function and durable tumour outcomes.
What would be measured: Clonal survival versus recruitment, durable chromatin and cytotoxic changes, objective tumour control and progression or survival, analyzed by baseline stratum
Important controls: Antigen-specific and bystander controls, receptor-signature versus killing assays, equivalent target engagement, terminal versus progenitor tracing, and matched stromal or presentation rescue
Result that would support the claim: In most representative strata direct exhaustion-program reversal accounts for the largest causal control effect, traced terminal clones recover durably, and alternative barrier removal adds little with verified engagement
Result that would count against it: Benefit depends on progenitors, new clones or another baseline barrier, or terminal signatures change without function and persistence
Explore the evidence
Read the complete scientific review.
Follow the studies, detailed comparisons and evidence ratings behind this guide.
Open the scientific review →